← All organizations
Highest phase reached
Phase 2
First clinical trial
Jun 1, 2003Last known activity
Jan 1, 2011
Timeline
1990s
- Jun 1, 1997
Translational Oncology Research International— Founded
Drugs by trial phase (16 distinct, 11 trials)
Phase 2 (16 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT01234935Overall official - principal investigatorPhase 2Jan 1, 2011
- NCT01234935Lead sponsorPhase 2Jan 1, 2011
- NCT00985192Lead sponsorPhase 2Sep 1, 2009
- NCT00769470Lead sponsorPhase 2Apr 1, 2009
- NCT00591123Lead sponsorPhase 2Dec 1, 2007
- NCT00203411Lead sponsorPhase 2Mar 1, 2006
- NCT00203424Lead sponsorPhase 2Jan 1, 2006
- NCT00203372Lead sponsorPhase 2May 1, 2005
- NCT00217672Lead sponsorPhase 2May 1, 2005
- NCT00138125Lead sponsorPhase 2Apr 1, 2005
- NCT00100854Lead sponsorPhase 2Oct 1, 2004
- NCT00095706Lead sponsorPhase 1/Phase 2Jun 1, 2003
Details
- Founded
- Los Angeles, CA, US Jun 1, 1997
- Last known activity
- Jan 1, 2011
Notes
CRO